Corvus Pharmaceuticals, Inc. (CRVS) insider have most recently took part in a trading activity. On Jun 23, 2017 Novo Holdings A/s, 10% Owner bought 20,000 shares having total worth of $219,000 at the price of $10.95 per share, following the transaction a total of 3,244,046 shares owned by Novo Holdings A/s.
The stock has experienced a total of 1 insider trades in the past three months. These trades include 1 buy trades. Furthermore, over the past 12 months , the stock was traded 3 times by insiders. an employee of the company was the buyer in 3 instances.
|Time Frame||Number of Insider Buy||Number of Insider Sell||Stock Price Change(%)|
Shares of Corvus Pharmaceuticals, Inc. (CRVS) traded up 7.35% on Jun 26, 2017, hitting $12.13. 139,653 shares of the company’s stock traded hands. Corvus Pharmaceuticals, Inc. has a 52 week low of $9.44 and a 52 week high of $21.37. The company’s market cap is $344 million.
Corvus Pharmaceuticals, Inc. (CRVS) last announced its earnings results on Mar 10, 2017. The company reported -0.55 earnings per share (EPS) for the quarter, higher than the consensus estimate of -0.57 by $0.02.
|earnings per share||-0.55|
Latest posts by William White (see all)
- Insider Trading Review: FS Investment Corporation $FSIC - January 13, 2018
- Insider Trader Watch: ENERTOPIA CORP $ENRT - January 13, 2018
- Insider Trading in Focus: Swiss Helvetia Fund, Inc. (The) $SWZ - January 13, 2018